Novartis Pharma AG

13 Archived Projects

Title Investigator Start End
Multicenter Study in treating Macular Edema Acharya
DDI study between HIV drugs (Efavirenz) and Coartem Aweeka
A Phase I Study to Assess the Bioequivalence of 2 Formulations of TKI258, FMI Capsule and FMI Tablet, in Patients with Advanced Solid Tumors Munster
Imaging Oncogene Activation and Tumor Development in Genetically Engineered Mice McMahon
Novartis Corporation Service Agreement Kelly
Phase IA, Multicenter, Open-label Dose Escalation Study of Oral BYL719, in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene Rugo
A Multicenter Phase I/II Trial of Abiraterone + BEZ235 in Metastatic, Castration-Resistant Prostate Cancer Ryan
A Phase II, Single Arm Study of the Use of Steroid-Based Mouthwash to Prevent Stomatitis in Postmenopausal Women with Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated with Everolimus plus Exemestane. Rugo
Phase II study of letrozole with or without BYL719 or buparlisib, for the neoadjuvant treatment of postmenopausal women with hormone receptor-positive HER2-negative breast cancer Rugo
Study of the histone deacetylase inhibitor Panobinostat (LBH589) in combination with standard dose Cytarabine and Daunorubicin for older patients with untreated acute Mmyeloid leukemia or advanced myelodysplasia Andreadis
Fingolimod Administered Orally Once Daily vs Interferon Beta-1a i.m. Once Weekly in Pediatric Patients with Multiple Sclerosis
A Single Arm, Open-Label, Multicenter Study Evaluating the Long-Term Safety, Tolerability and Efficacy of 0.5 Mg Fingolimod (Fty720) Administered Orally Once Daily in Patients with Multiple Sclerosis (MS) Goodin
BGJ398X2201 - A Phase 2, multicenter, open-label study of BGJ398 in patients with recurrent resectable or unresectable Glioblastoma Butowski